| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA uridylyltransferase activity | 7.88e-05 | 3 | 103 | 2 | GO:0050265 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 2.61e-04 | 5 | 103 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 2.82e-04 | 25 | 103 | 3 | GO:0031683 | |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 5.44e-04 | 7 | 103 | 2 | GO:0070569 | |
| GeneOntologyMolecularFunction | zinc ion binding | UBA5 UBR2 USP45 TUT4 ZEB1 RBBP6 TUT7 ZMYND8 ZNF407 KAT7 CTCF KMT2A PML | 6.64e-04 | 891 | 103 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 7.23e-04 | 8 | 103 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 8.41e-04 | 36 | 103 | 3 | GO:0070273 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 8.76e-04 | 143 | 103 | 5 | GO:0017124 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.15e-03 | 10 | 103 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.21e-03 | 229 | 103 | 6 | GO:0140993 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | UBR2 ARID4B RBBP5 ZMYND8 JMJD1C KAT7 KMT2C GTF2E1 SAFB CTCF ABRAXAS1 NFRKB PAXIP1 KMT2A TASOR UTY PML | 5.03e-06 | 999 | 99 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | UBR2 ARID4B RBBP5 ZMYND8 JMJD1C KAT7 KMT2C SAFB CTCF ABRAXAS1 NFRKB PAXIP1 KMT2A TASOR UTY PML | 5.40e-06 | 896 | 99 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | UBR2 ARID4B RBBP5 JMJD1C KAT7 KMT2C CTCF NFRKB PAXIP1 KMT2A TASOR UTY PML | 5.37e-05 | 741 | 99 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein targeting to Golgi apparatus | 6.82e-05 | 3 | 99 | 2 | GO:0140450 | |
| GeneOntologyBiologicalProcess | polyuridylation-dependent mRNA catabolic process | 6.82e-05 | 3 | 99 | 2 | GO:1990074 | |
| GeneOntologyBiologicalProcess | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 1.22e-04 | 53 | 99 | 4 | GO:0006890 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.78e-07 | 12 | 104 | 4 | GO:0044666 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.00e-06 | 75 | 104 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.66e-05 | 108 | 104 | 6 | GO:0034708 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ARID4B RBBP5 NVL JMJD1C INTS10 KAT7 KMT2C GTF2E1 UPF2 ABRAXAS1 ASXL3 NFRKB PAXIP1 KMT2A BOD1L1 ANAPC5 UTY TGS1 | 1.43e-04 | 1377 | 104 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 6.97e-04 | 35 | 104 | 3 | GO:0005834 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 8.63e-04 | 9 | 104 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | transferase complex | UBR2 RAD18 RBBP5 TBC1D5 DHDDS KAT7 KMT2C GTF2E1 PAXIP1 KMT2A BOD1L1 ANAPC5 UTY | 9.78e-04 | 963 | 104 | 13 | GO:1990234 |
| GeneOntologyCellularComponent | GTPase complex | 1.11e-03 | 41 | 104 | 3 | GO:1905360 | |
| Domain | - | UBR2 RAD18 USP45 RBBP6 ZMYND8 DIDO1 KMT2C GTF2E1 RNF123 KMT2A PML PDZRN4 | 4.49e-06 | 449 | 99 | 12 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | UBR2 RAD18 USP45 RBBP6 ZMYND8 DIDO1 KMT2C GTF2E1 RNF123 KMT2A PML PDZRN4 | 5.62e-06 | 459 | 99 | 12 | IPR013083 |
| Domain | Gprotein_alpha_I | 7.94e-06 | 8 | 99 | 3 | IPR001408 | |
| Domain | GPP34 | 2.78e-05 | 2 | 99 | 2 | IPR008628 | |
| Domain | GPP34 | 2.78e-05 | 2 | 99 | 2 | PF05719 | |
| Domain | EIF3C_N_dom | 2.78e-05 | 2 | 99 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 2.78e-05 | 2 | 99 | 2 | PF05470 | |
| Domain | EIF3C | 2.78e-05 | 2 | 99 | 2 | IPR027516 | |
| Domain | G-alpha | 7.69e-05 | 16 | 99 | 3 | PF00503 | |
| Domain | GproteinA_insert | 7.69e-05 | 16 | 99 | 3 | IPR011025 | |
| Domain | - | 7.69e-05 | 16 | 99 | 3 | 1.10.400.10 | |
| Domain | G_alpha | 7.69e-05 | 16 | 99 | 3 | SM00275 | |
| Domain | Gprotein_alpha_su | 9.31e-05 | 17 | 99 | 3 | IPR001019 | |
| Domain | ZF_PHD_2 | 1.50e-04 | 95 | 99 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.58e-04 | 96 | 99 | 5 | PS01359 | |
| Domain | zf-CCHC | 2.37e-04 | 23 | 99 | 3 | PF00098 | |
| Domain | FYrich_C | 2.75e-04 | 5 | 99 | 2 | IPR003889 | |
| Domain | FYrich_N | 2.75e-04 | 5 | 99 | 2 | IPR003888 | |
| Domain | FYRC | 2.75e-04 | 5 | 99 | 2 | SM00542 | |
| Domain | FYRN | 2.75e-04 | 5 | 99 | 2 | SM00541 | |
| Domain | DOCK_N | 2.75e-04 | 5 | 99 | 2 | PF16172 | |
| Domain | DOCK_N | 2.75e-04 | 5 | 99 | 2 | IPR032376 | |
| Domain | FYRN | 2.75e-04 | 5 | 99 | 2 | PF05964 | |
| Domain | FYRC | 2.75e-04 | 5 | 99 | 2 | PF05965 | |
| Domain | FYRC | 2.75e-04 | 5 | 99 | 2 | PS51543 | |
| Domain | FYRN | 2.75e-04 | 5 | 99 | 2 | PS51542 | |
| Domain | - | 3.44e-04 | 26 | 99 | 3 | 4.10.60.10 | |
| Domain | AT_hook | 3.85e-04 | 27 | 99 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 3.85e-04 | 27 | 99 | 3 | IPR017956 | |
| Domain | SPOC_C | 4.11e-04 | 6 | 99 | 2 | IPR012921 | |
| Domain | SPOC | 4.11e-04 | 6 | 99 | 2 | PF07744 | |
| Domain | PAP_assoc | 5.74e-04 | 7 | 99 | 2 | PF03828 | |
| Domain | PAP_assoc | 5.74e-04 | 7 | 99 | 2 | IPR002058 | |
| Domain | PHD | 6.77e-04 | 75 | 99 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 8.23e-04 | 79 | 99 | 4 | IPR019787 | |
| Domain | ZF_CCHC | 8.36e-04 | 35 | 99 | 3 | PS50158 | |
| Domain | PDZ | 9.25e-04 | 141 | 99 | 5 | PF00595 | |
| Domain | SH3 | 1.02e-03 | 216 | 99 | 6 | SM00326 | |
| Domain | SH3 | 1.02e-03 | 216 | 99 | 6 | PS50002 | |
| Domain | ZF_RING_2 | 1.04e-03 | 298 | 99 | 7 | PS50089 | |
| Domain | SH3_domain | 1.12e-03 | 220 | 99 | 6 | IPR001452 | |
| Domain | PDZ | 1.15e-03 | 148 | 99 | 5 | SM00228 | |
| Domain | RING | 1.19e-03 | 305 | 99 | 7 | SM00184 | |
| Domain | - | 1.22e-03 | 150 | 99 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.26e-03 | 151 | 99 | 5 | PS50106 | |
| Domain | PHD | 1.28e-03 | 89 | 99 | 4 | SM00249 | |
| Domain | PDZ | 1.29e-03 | 152 | 99 | 5 | IPR001478 | |
| Domain | Znf_PHD | 1.39e-03 | 91 | 99 | 4 | IPR001965 | |
| Domain | NTP_transf_2 | 1.48e-03 | 11 | 99 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 1.48e-03 | 11 | 99 | 2 | IPR002934 | |
| Domain | DOCK_C | 1.48e-03 | 11 | 99 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.48e-03 | 11 | 99 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.48e-03 | 11 | 99 | 2 | PS51651 | |
| Domain | DHR_1 | 1.48e-03 | 11 | 99 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.48e-03 | 11 | 99 | 2 | PF14429 | |
| Domain | DHR-2 | 1.48e-03 | 11 | 99 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.48e-03 | 11 | 99 | 2 | PF06920 | |
| Domain | DOCK | 1.48e-03 | 11 | 99 | 2 | IPR026791 | |
| Domain | Znf_RING | 1.75e-03 | 326 | 99 | 7 | IPR001841 | |
| Domain | OTU | 2.09e-03 | 13 | 99 | 2 | PF02338 | |
| Domain | OTU | 2.79e-03 | 15 | 99 | 2 | PS50802 | |
| Domain | OTU_dom | 2.79e-03 | 15 | 99 | 2 | IPR003323 | |
| Domain | ZnF_C2HC | 3.10e-03 | 55 | 99 | 3 | SM00343 | |
| Domain | Znf_CCHC | 3.10e-03 | 55 | 99 | 3 | IPR001878 | |
| Domain | Post-SET_dom | 3.18e-03 | 16 | 99 | 2 | IPR003616 | |
| Domain | PostSET | 3.18e-03 | 16 | 99 | 2 | SM00508 | |
| Domain | PINT | 3.18e-03 | 16 | 99 | 2 | SM00088 | |
| Domain | AT_hook | 3.18e-03 | 16 | 99 | 2 | PF02178 | |
| Domain | POST_SET | 3.18e-03 | 16 | 99 | 2 | PS50868 | |
| Domain | PCI_dom | 3.59e-03 | 17 | 99 | 2 | IPR000717 | |
| Domain | PCI | 3.59e-03 | 17 | 99 | 2 | PF01399 | |
| Domain | ZF_RING_1 | 4.54e-03 | 291 | 99 | 6 | PS00518 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.54e-06 | 42 | 74 | 5 | M48018 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 7.63e-06 | 8 | 74 | 3 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 7.63e-06 | 8 | 74 | 3 | M47643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.14e-05 | 9 | 74 | 3 | M47641 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 2.22e-05 | 11 | 74 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 2.95e-05 | 12 | 74 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 2.95e-05 | 12 | 74 | 3 | M47559 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 4.51e-05 | 38 | 74 | 4 | MM17073 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 4.85e-05 | 14 | 74 | 3 | M64 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 4.85e-05 | 14 | 74 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 4.85e-05 | 14 | 74 | 3 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 8.96e-05 | 17 | 74 | 3 | M47544 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 1.73e-04 | 21 | 74 | 3 | M103 | |
| Pathway | PID_S1P_META_PATHWAY | 1.73e-04 | 21 | 74 | 3 | M155 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.99e-04 | 22 | 74 | 3 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.99e-04 | 22 | 74 | 3 | M841 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 2.28e-04 | 23 | 74 | 3 | MM15952 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 2.60e-04 | 24 | 74 | 3 | M268 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 2.94e-04 | 25 | 74 | 3 | M39384 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.31e-04 | 26 | 74 | 3 | M47553 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 3.31e-04 | 26 | 74 | 3 | M47439 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 3.65e-04 | 254 | 74 | 7 | M27131 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.71e-04 | 27 | 74 | 3 | M47519 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 3.94e-04 | 66 | 74 | 4 | M39684 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.60e-04 | 29 | 74 | 3 | M48076 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 4.60e-04 | 29 | 74 | 3 | M55 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 5.61e-04 | 7 | 74 | 2 | M47869 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 5.62e-04 | 31 | 74 | 3 | M213 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 6.77e-04 | 33 | 74 | 3 | MM15020 | |
| Pathway | WP_PURINERGIC_SIGNALING | 6.77e-04 | 33 | 74 | 3 | M39855 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 6.77e-04 | 33 | 74 | 3 | M9379 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 9.49e-04 | 37 | 74 | 3 | M42558 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 1.03e-03 | 85 | 74 | 4 | M3578 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.11e-03 | 39 | 74 | 3 | MM14496 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 1.19e-03 | 40 | 74 | 3 | M41 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.27e-03 | 90 | 74 | 4 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.32e-03 | 91 | 74 | 4 | M39426 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.45e-03 | 11 | 74 | 2 | M42562 | |
| Pathway | PID_CXCR3_PATHWAY | 1.47e-03 | 43 | 74 | 3 | M222 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.47e-03 | 43 | 74 | 3 | M29837 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 1.47e-03 | 43 | 74 | 3 | M238 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.47e-03 | 43 | 74 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.58e-03 | 44 | 74 | 3 | MM15709 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.68e-03 | 45 | 74 | 3 | M45008 | |
| Pathway | REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS | 1.73e-03 | 12 | 74 | 2 | M48027 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 2.03e-03 | 48 | 74 | 3 | M219 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.03e-03 | 48 | 74 | 3 | M10775 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.25e-03 | 175 | 74 | 5 | MM14941 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.41e-03 | 450 | 74 | 8 | M27078 | |
| Pathway | WP_5Q35_COPY_NUMBER_VARIATION | 2.74e-03 | 111 | 74 | 4 | M48089 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.84e-03 | 54 | 74 | 3 | M26911 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.02e-03 | 272 | 74 | 6 | M29619 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 3.15e-03 | 56 | 74 | 3 | M839 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 3.51e-03 | 17 | 74 | 2 | M48025 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RAD18 ARID4B RBBP5 RBBP6 ZMYND8 DIDO1 JMJD1C INTS10 KAT7 KMT2C SAFB CTCF ABRAXAS1 NFRKB PAXIP1 KMT2A SLC7A5 SPEN TASOR ANAPC5 CDCA5 | 2.20e-10 | 1294 | 104 | 21 | 30804502 |
| Pubmed | SHROOM3 RBBP5 RBBP6 ZMYND8 DIDO1 DHX57 CLASP2 EDC4 INTS10 RMDN3 KMT2C CTCF NFRKB OTUD4 KMT2A SLC7A5 CEP131 EIF3C SPEN TASOR ANAPC5 ZHX1 | 4.95e-10 | 1497 | 104 | 22 | 31527615 | |
| Pubmed | RAD18 ZEB1 ARID4B RBBP5 RBBP6 ZMYND8 DIDO1 EDC4 JMJD1C KMT2C CTCF PAX8 NFRKB PAXIP1 OTUD4 KMT2A CEP131 EIF3C SPEN ZHX1 PML | 1.31e-09 | 1429 | 104 | 21 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAD18 ZEB1 ARID4B RBBP6 ZMYND8 DIDO1 EIF3CL SAFB NFRKB OTUD4 KMT2A SLC7A5 EIF3C SPEN ANAPC5 ZHX1 | 1.34e-09 | 774 | 104 | 16 | 15302935 |
| Pubmed | RAD18 MIA3 USP45 DZIP1L TUT7 DHDDS DIDO1 CLASP2 AKAP12 KAT7 KMT2C NFRKB OTUD4 BOD1L1 GNAI3 TASOR PML TGS1 | 3.56e-09 | 1084 | 104 | 18 | 11544199 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RAD18 ARID4B RBBP5 NVL DIDO1 JMJD1C KAT7 GTF2E1 ABRAXAS1 NFRKB KMT2A BOD1L1 SPEN ZHX1 | 4.03e-09 | 608 | 104 | 14 | 36089195 |
| Pubmed | 4.62e-09 | 251 | 104 | 10 | 31076518 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 5.49e-09 | 22 | 104 | 5 | 26886794 | |
| Pubmed | 8.82e-09 | 50 | 104 | 6 | 37974198 | ||
| Pubmed | MIA3 RBBP5 TBC1D5 TUT7 DIDO1 DHX57 JMJD1C RGS3 UPF2 ELMO2 KMT2A TASOR ANAPC5 PLCE1 | 9.36e-09 | 650 | 104 | 14 | 38777146 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DOCK3 RBBP6 GSDMB DIDO1 CLASP2 JMJD1C SAFB ASXL3 HADH MYO18B SPEN | 1.22e-08 | 361 | 104 | 11 | 26167880 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RBBP6 TBC1D5 SH3GL1 ZMYND8 DIDO1 EDC4 AKAP12 GTF2E1 SAFB CTCF KMT2A BOD1L1 EIF3C TASOR PML AHNAK2 | 1.88e-08 | 934 | 104 | 16 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RAD18 ARID4B RBBP6 ZMYND8 NVL DIDO1 JMJD1C SAFB CTCF NFRKB KMT2A BOD1L1 SPEN TASOR CDCA5 PML | 2.52e-08 | 954 | 104 | 16 | 36373674 |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 16962188 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 15788486 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 17484771 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 29342363 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 30836096 | ||
| Pubmed | RBBP5 ZNF407 CLASP2 JMJD1C AKAP12 UPF2 RALBP1 EIF3C NOSTRIN MYO18B PLCE1 TGS1 | 3.34e-08 | 497 | 104 | 12 | 23414517 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 8.31e-08 | 341 | 104 | 10 | 32971831 | |
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 1.04e-07 | 4 | 104 | 3 | 11248120 | |
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 17635935 | ||
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 11771389 | ||
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 19703992 | ||
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 11168387 | ||
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 24081332 | ||
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 1.04e-07 | 4 | 104 | 3 | 18832081 | |
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 21931697 | ||
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 28145731 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.09e-07 | 351 | 104 | 10 | 38297188 | |
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 12860983 | ||
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 30617251 | ||
| Pubmed | Coupling of dopamine receptor subtypes to multiple and diverse G proteins. | 2.59e-07 | 5 | 104 | 3 | 10978845 | |
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 26373672 | ||
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 16298104 | ||
| Pubmed | Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. | 2.59e-07 | 5 | 104 | 3 | 22706085 | |
| Pubmed | Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. | 2.59e-07 | 5 | 104 | 3 | 2820999 | |
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 22230296 | ||
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 11387333 | ||
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 24415754 | ||
| Pubmed | RAD18 RBBP6 DIDO1 EIF3CL KAT7 SAFB OTUD4 CEP131 EIF3C SPEN CDCA5 | 3.45e-07 | 503 | 104 | 11 | 16964243 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 3.52e-07 | 20 | 104 | 4 | 29785026 | |
| Pubmed | 3.52e-07 | 20 | 104 | 4 | 19047629 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 25078664 | ||
| Pubmed | Identification of the platelet ADP receptor targeted by antithrombotic drugs. | 5.16e-07 | 6 | 104 | 3 | 11196645 | |
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 16371464 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 23236180 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 19401591 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 30975754 | ||
| Pubmed | Cloning and characterization of a novel regulator of G protein signalling in human platelets. | 5.16e-07 | 6 | 104 | 3 | 11955952 | |
| Pubmed | Characterization of RGS5 in regulation of G protein-coupled receptor signaling. | 5.16e-07 | 6 | 104 | 3 | 11253162 | |
| Pubmed | 6.28e-07 | 425 | 104 | 10 | 24999758 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | RAD18 DHX57 CLASP2 RMDN3 SAFB ABRAXAS1 PAXIP1 GALNTL5 ANAPC5 GPN3 STOML2 PML | 8.15e-07 | 670 | 104 | 12 | 22990118 |
| Pubmed | 8.71e-07 | 339 | 104 | 9 | 30415952 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 15251452 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 26324722 | ||
| Pubmed | Activation state-dependent interaction between Galphai and p67phox. | 9.01e-07 | 7 | 104 | 3 | 16782902 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 8986788 | ||
| Pubmed | CERK RAD18 TUT4 ARID4B RBBP6 ZMYND8 ABCA7 INTS10 KAT7 RMDN3 CTCF RTL9 NFRKB ANAPC5 PML | 1.19e-06 | 1116 | 104 | 15 | 31753913 | |
| Pubmed | Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. | 1.44e-06 | 8 | 104 | 3 | 12509430 | |
| Pubmed | RBBP5 RBBP6 ZMYND8 NVL KAT7 SAFB CTCF KMT2A SLC7A5 GNAI1 GNAI2 EIF3C TASOR | 1.54e-06 | 847 | 104 | 13 | 35850772 | |
| Pubmed | 1.63e-06 | 119 | 104 | 6 | 23508102 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RAD18 CLASP2 EDC4 AKAP12 EIF3CL RMDN3 CTCF CEP131 GNAI1 GNAI2 GNAI3 EIF3C ANAPC5 CDCA5 TGS1 | 1.81e-06 | 1155 | 104 | 15 | 20360068 |
| Pubmed | MIA3 TUT4 TUT7 NVL CLASP2 JMJD1C NFRKB SLC7A5 BOD1L1 CEP131 TASOR TGS1 | 2.07e-06 | 733 | 104 | 12 | 34672954 | |
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 2.15e-06 | 9 | 104 | 3 | 38651641 | |
| Pubmed | 2.15e-06 | 9 | 104 | 3 | 22665483 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.28e-06 | 283 | 104 | 8 | 30585729 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | UBA5 RAD18 TBC1D5 OSER1 CLASP2 EDC4 KAT7 UPF2 PAXIP1 OTUD4 EIF3C ANAPC5 GPN3 TGS1 | 2.68e-06 | 1038 | 104 | 14 | 26673895 |
| Pubmed | 3.07e-06 | 10 | 104 | 3 | 26755700 | ||
| Pubmed | 3.07e-06 | 10 | 104 | 3 | 8552586 | ||
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 3.07e-06 | 10 | 104 | 3 | 8521505 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 3.25e-06 | 134 | 104 | 6 | 25452129 | |
| Pubmed | 5.60e-06 | 12 | 104 | 3 | 27563068 | ||
| Pubmed | Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse. | 5.60e-06 | 12 | 104 | 3 | 2508088 | |
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 5.60e-06 | 12 | 104 | 3 | 9611134 | |
| Pubmed | RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao. | 5.60e-06 | 12 | 104 | 3 | 10926822 | |
| Pubmed | RBBP6 SH3GL1 DIDO1 EDC4 JMJD1C KMT2C NFRKB KMT2A BOD1L1 SPEN | 6.13e-06 | 549 | 104 | 10 | 38280479 | |
| Pubmed | SHROOM3 MIA3 ZEB1 TBC1D5 DIDO1 CLASP2 EDC4 AKAP12 CTCF OTUD4 CEP131 GNAI1 STOML2 | 6.21e-06 | 963 | 104 | 13 | 28671696 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 6.40e-06 | 231 | 104 | 7 | 36597993 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | UBA5 RBBP5 SH3GL1 ZMYND8 NVL JMJD1C AKAP12 KAT7 RMDN3 KMT2C SAFB EIF3C ANAPC5 ZHX1 | 6.65e-06 | 1124 | 104 | 14 | 21900206 |
| Pubmed | 7.27e-06 | 13 | 104 | 3 | 21930703 | ||
| Pubmed | Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. | 7.27e-06 | 13 | 104 | 3 | 8208289 | |
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 7.27e-06 | 13 | 104 | 3 | 17761849 | |
| Pubmed | Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. | 7.27e-06 | 13 | 104 | 3 | 16892066 | |
| Pubmed | A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells. | 7.27e-06 | 13 | 104 | 3 | 24135232 | |
| Pubmed | 7.87e-06 | 335 | 104 | 8 | 15741177 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 27881871 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 33623141 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22674806 | ||
| Pubmed | The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses. | 8.86e-06 | 2 | 104 | 2 | 28665939 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 34949722 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23660685 | ||
| Pubmed | Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice. | 8.86e-06 | 2 | 104 | 2 | 25944935 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28108543 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17763464 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24085765 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22858909 | ||
| Pubmed | Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling. | 8.86e-06 | 2 | 104 | 2 | 17289675 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18024407 | ||
| Pubmed | Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils. | 8.86e-06 | 2 | 104 | 2 | 26976957 | |
| Interaction | KMT2C interactions | 3.12e-08 | 134 | 104 | 9 | int:KMT2C | |
| Interaction | H3-3A interactions | RAD18 ARID4B RBBP5 NVL DIDO1 JMJD1C KAT7 KMT2C GTF2E1 ABRAXAS1 RALBP1 NFRKB KMT2A BOD1L1 SPEN CDCA5 ZHX1 PML | 4.95e-08 | 749 | 104 | 18 | int:H3-3A |
| Interaction | H2BC8 interactions | UBR2 RAD18 ZEB1 ARID4B RBBP5 ZMYND8 NVL DIDO1 KAT7 CTCF NFRKB KMT2A SPEN TASOR CDCA5 | 2.65e-07 | 576 | 104 | 15 | int:H2BC8 |
| Interaction | BUB3 interactions | RAD18 PAGE4 RBBP5 CLASP2 KMT2C ASXL3 PAXIP1 KMT2A BOD1L1 PML | 3.42e-07 | 232 | 104 | 10 | int:BUB3 |
| Interaction | H3C1 interactions | RAD18 ARID4B RBBP5 ZMYND8 DIDO1 JMJD1C KAT7 KMT2C GTF2E1 CTCF RALBP1 PAXIP1 KMT2A SLC7A5 EIF3C SPEN ANAPC5 CDCA5 | 7.58e-07 | 901 | 104 | 18 | int:H3C1 |
| Interaction | MEN1 interactions | RBBP5 RBBP6 ZMYND8 NVL DIDO1 EDC4 JMJD1C KAT7 KMT2C SAFB UPF2 CTCF PAXIP1 KMT2A SLC7A5 BOD1L1 EIF3C SPEN TASOR | 1.17e-06 | 1029 | 104 | 19 | int:MEN1 |
| Interaction | NFIX interactions | 2.71e-06 | 227 | 104 | 9 | int:NFIX | |
| Interaction | CSNK2B interactions | RAD18 USP45 RBBP5 ZMYND8 DIDO1 KAT7 CTCF RALBP1 NFRKB PAXIP1 KMT2A EIF3C ZHX1 PML | 4.00e-06 | 625 | 104 | 14 | int:CSNK2B |
| Interaction | NUP43 interactions | ARID4B RBBP5 RBBP6 ZMYND8 JMJD1C SAFB CTCF NFRKB KMT2A BOD1L1 SPEN CDCA5 ZHX1 AHNAK2 | 4.00e-06 | 625 | 104 | 14 | int:NUP43 |
| Interaction | KMT2B interactions | 4.99e-06 | 130 | 104 | 7 | int:KMT2B | |
| Interaction | MYB interactions | 5.81e-06 | 133 | 104 | 7 | int:MYB | |
| Interaction | HNF1B interactions | 6.41e-06 | 190 | 104 | 8 | int:HNF1B | |
| Interaction | NRP1 interactions | UBR2 TGOLN2 RMDN3 SAFB SNX32 GNAI1 GNAI2 GNAI3 STOML2 AHNAK2 | 6.89e-06 | 324 | 104 | 10 | int:NRP1 |
| Interaction | RBBP4 interactions | RAD18 ZEB1 ARID4B RBBP5 ZMYND8 TGOLN2 SAFB CTCF ASXL3 KMT2A SPEN CDCA5 ZHX1 | 7.95e-06 | 573 | 104 | 13 | int:RBBP4 |
| Interaction | HCFC2 interactions | 8.13e-06 | 92 | 104 | 6 | int:HCFC2 | |
| Interaction | NCOA6 interactions | 1.02e-05 | 145 | 104 | 7 | int:NCOA6 | |
| Interaction | FEV interactions | 1.04e-05 | 203 | 104 | 8 | int:FEV | |
| Interaction | RGS18 interactions | 1.10e-05 | 9 | 104 | 3 | int:RGS18 | |
| Interaction | HNF4A interactions | 1.28e-05 | 275 | 104 | 9 | int:HNF4A | |
| Interaction | PAXIP1 interactions | RBBP5 KMT2C PAX8 ABRAXAS1 PAXIP1 KMT2A BOD1L1 ANAPC5 STOML2 PML | 1.68e-05 | 359 | 104 | 10 | int:PAXIP1 |
| Interaction | RBBP5 interactions | 1.79e-05 | 287 | 104 | 9 | int:RBBP5 | |
| Interaction | KDM6A interactions | 2.10e-05 | 162 | 104 | 7 | int:KDM6A | |
| Interaction | EN1 interactions | 2.27e-05 | 110 | 104 | 6 | int:EN1 | |
| Interaction | KMT2D interactions | 2.76e-05 | 169 | 104 | 7 | int:KMT2D | |
| Interaction | TERF2IP interactions | RAD18 ZEB1 RBBP6 ZMYND8 DIDO1 CTCF NFRKB KMT2A BOD1L1 SPEN TASOR PML | 2.77e-05 | 552 | 104 | 12 | int:TERF2IP |
| Interaction | RGS5 interactions | 2.84e-05 | 12 | 104 | 3 | int:RGS5 | |
| Interaction | SETD1A interactions | 2.87e-05 | 170 | 104 | 7 | int:SETD1A | |
| Interaction | PAK5 interactions | 2.92e-05 | 115 | 104 | 6 | int:PAK5 | |
| Interaction | FAM3C interactions | 3.54e-05 | 119 | 104 | 6 | int:FAM3C | |
| Interaction | NPM1 interactions | DOCK4 RAD18 ZEB1 PAGE4 ZMYND8 NVL DIDO1 DHX57 EDC4 AKAP12 TGOLN2 CTCF ELMO2 KMT2A GNAI2 EIF3C PML AHNAK2 | 3.96e-05 | 1201 | 104 | 18 | int:NPM1 |
| Interaction | NAA40 interactions | RBBP6 TBC1D5 SH3GL1 ZMYND8 DIDO1 EDC4 AKAP12 GTF2E1 SAFB CTCF KMT2A BOD1L1 EIF3C TASOR PML AHNAK2 | 4.00e-05 | 978 | 104 | 16 | int:NAA40 |
| Interaction | SETD1B interactions | 4.30e-05 | 75 | 104 | 5 | int:SETD1B | |
| Interaction | SMC5 interactions | RAD18 ARID4B RBBP6 ZMYND8 NVL DIDO1 JMJD1C SAFB CTCF NFRKB KMT2A BOD1L1 SPEN TASOR CDCA5 PML | 5.21e-05 | 1000 | 104 | 16 | int:SMC5 |
| Interaction | TOP3B interactions | DOCK3 ARHGEF19 SHROOM3 DHX57 CLASP2 EDC4 ABCA7 SIL1 KMT2C SAFB UPF2 PAXIP1 OTUD4 SLC7A5 CEP131 GNAI1 GNAI2 GNAI3 SPEN AHNAK2 | 5.48e-05 | 1470 | 104 | 20 | int:TOP3B |
| Interaction | H2BC4 interactions | 5.94e-05 | 259 | 104 | 8 | int:H2BC4 | |
| Interaction | CXXC1 interactions | 6.32e-05 | 132 | 104 | 6 | int:CXXC1 | |
| Interaction | GNG10 interactions | 7.07e-05 | 43 | 104 | 4 | int:GNG10 | |
| Interaction | GNAT3 interactions | 7.12e-05 | 16 | 104 | 3 | int:GNAT3 | |
| Interaction | PAX2 interactions | 7.85e-05 | 85 | 104 | 5 | int:PAX2 | |
| Interaction | XRCC6 interactions | ZEB1 RBBP6 ZMYND8 NVL DIDO1 JMJD1C GTF2E1 RNF123 KIF9 ASXL3 PAXIP1 KMT2A BOD1L1 SPEN CDCA5 | 8.18e-05 | 928 | 104 | 15 | int:XRCC6 |
| Interaction | RGS12 interactions | 8.47e-05 | 45 | 104 | 4 | int:RGS12 | |
| Interaction | AGTR2 interactions | 8.61e-05 | 17 | 104 | 3 | int:AGTR2 | |
| Interaction | GNG11 interactions | 8.61e-05 | 17 | 104 | 3 | int:GNG11 | |
| Interaction | RGS16 interactions | 8.61e-05 | 17 | 104 | 3 | int:RGS16 | |
| Interaction | NHLH1 interactions | 9.27e-05 | 88 | 104 | 5 | int:NHLH1 | |
| Interaction | TP53BP1 interactions | RAD18 ZEB1 CLASP2 JMJD1C SAFB ABRAXAS1 PAXIP1 GALNTL5 SLC7A5 ANAPC5 PML | 9.69e-05 | 533 | 104 | 11 | int:TP53BP1 |
| Interaction | CNR1 interactions | 1.03e-04 | 18 | 104 | 3 | int:CNR1 | |
| Interaction | CSNK2A1 interactions | RAD18 ZEB1 ARID4B RBBP5 ZMYND8 CLASP2 EIF3CL KAT7 SAFB ASXL3 PAXIP1 KMT2A EIF3C ZHX1 PML | 1.14e-04 | 956 | 104 | 15 | int:CSNK2A1 |
| Interaction | PAX6 interactions | 1.17e-04 | 366 | 104 | 9 | int:PAX6 | |
| Interaction | SERBP1 interactions | UBA5 SHROOM3 RAD18 ZEB1 PAGE4 TUT7 DIDO1 DHX57 GOLPH3 AKAP12 RNF123 UPF2 GOLPH3L CTCF OTUD4 SLC7A5 HADH ANAPC5 STOML2 | 1.21e-04 | 1432 | 104 | 19 | int:SERBP1 |
| Interaction | BOD1L1 interactions | 1.23e-04 | 149 | 104 | 6 | int:BOD1L1 | |
| Interaction | PAGR1 interactions | 1.39e-04 | 51 | 104 | 4 | int:PAGR1 | |
| Interaction | DIPK2A interactions | 1.39e-04 | 51 | 104 | 4 | int:DIPK2A | |
| Interaction | HCFC1 interactions | 1.40e-04 | 293 | 104 | 8 | int:HCFC1 | |
| Interaction | GNG7 interactions | 1.43e-04 | 20 | 104 | 3 | int:GNG7 | |
| Interaction | MAN1B1 interactions | 1.47e-04 | 97 | 104 | 5 | int:MAN1B1 | |
| Interaction | YAP1 interactions | ZEB1 RBBP6 SH3GL1 DIDO1 EDC4 JMJD1C KMT2C NFRKB KMT2A BOD1L1 GNAI1 GNAI2 GNAI3 SPEN GPN3 PML | 1.50e-04 | 1095 | 104 | 16 | int:YAP1 |
| Interaction | USP17L12 interactions | 1.57e-04 | 4 | 104 | 2 | int:USP17L12 | |
| Interaction | PCDHA5 interactions | 1.57e-04 | 4 | 104 | 2 | int:PCDHA5 | |
| Interaction | ELF2 interactions | 1.59e-04 | 156 | 104 | 6 | int:ELF2 | |
| Interaction | H3C14 interactions | 1.59e-04 | 156 | 104 | 6 | int:H3C14 | |
| Interaction | WDR5 interactions | FLT3 RBBP5 EDC4 KMT2C CTCF ASXL3 PAXIP1 KMT2A BOD1L1 GNAI2 GNAI3 EIF3C CDCA5 UTY STOML2 PML | 1.60e-04 | 1101 | 104 | 16 | int:WDR5 |
| Interaction | PCP2 interactions | 1.66e-04 | 21 | 104 | 3 | int:PCP2 | |
| Interaction | SYMPK interactions | 1.67e-04 | 225 | 104 | 7 | int:SYMPK | |
| Interaction | HDAC1 interactions | ZEB1 ARID4B RBBP5 ZMYND8 JMJD1C RNF123 CTCF RALBP1 KMT2A CEP131 EIF3C SPEN TASOR ZHX1 PML S100PBP | 1.72e-04 | 1108 | 104 | 16 | int:HDAC1 |
| Interaction | KLF3 interactions | 1.81e-04 | 228 | 104 | 7 | int:KLF3 | |
| Interaction | SAP18 interactions | 1.84e-04 | 305 | 104 | 8 | int:SAP18 | |
| Interaction | UTY interactions | 2.19e-04 | 23 | 104 | 3 | int:UTY | |
| Interaction | NCL interactions | RAD18 ZEB1 ARID4B PAGE4 ZMYND8 DIDO1 RNF123 CTCF ASXL3 KMT2A OTUD3 EIF3C PML | 2.35e-04 | 798 | 104 | 13 | int:NCL |
| Interaction | BRD3 interactions | RAD18 RBBP6 ZMYND8 EIF3CL KAT7 RNF123 CTCF NFRKB KMT2A ANAPC5 | 2.38e-04 | 494 | 104 | 10 | int:BRD3 |
| Interaction | H3C3 interactions | RAD18 RBBP5 DIDO1 JMJD1C KAT7 GTF2E1 NFRKB KMT2A BOD1L1 SPEN | 2.42e-04 | 495 | 104 | 10 | int:H3C3 |
| Interaction | SRGAP3 interactions | 2.45e-04 | 59 | 104 | 4 | int:SRGAP3 | |
| Interaction | DYNLT1 interactions | 2.54e-04 | 241 | 104 | 7 | int:DYNLT1 | |
| Interaction | EGR2 interactions | 2.61e-04 | 171 | 104 | 6 | int:EGR2 | |
| Interaction | POLK interactions | 2.61e-04 | 60 | 104 | 4 | int:POLK | |
| Interaction | DOCK5 interactions | 2.76e-04 | 111 | 104 | 5 | int:DOCK5 | |
| Interaction | MZT1 interactions | 2.79e-04 | 61 | 104 | 4 | int:MZT1 | |
| Interaction | PDS5A interactions | 2.81e-04 | 245 | 104 | 7 | int:PDS5A | |
| Interaction | GNG4 interactions | 2.83e-04 | 25 | 104 | 3 | int:GNG4 | |
| Interaction | H2AC4 interactions | 2.88e-04 | 506 | 104 | 10 | int:H2AC4 | |
| Interaction | RBBP7 interactions | 2.93e-04 | 507 | 104 | 10 | int:RBBP7 | |
| Interaction | TBR1 interactions | 3.00e-04 | 113 | 104 | 5 | int:TBR1 | |
| Interaction | TEAD1 interactions | 3.05e-04 | 176 | 104 | 6 | int:TEAD1 | |
| Interaction | PRDX2 interactions | 3.07e-04 | 329 | 104 | 8 | int:PRDX2 | |
| Interaction | TPST1 interactions | 3.18e-04 | 26 | 104 | 3 | int:TPST1 | |
| Interaction | ELF4 interactions | 3.25e-04 | 115 | 104 | 5 | int:ELF4 | |
| Interaction | TBXT interactions | 3.38e-04 | 116 | 104 | 5 | int:TBXT | |
| Interaction | CRX interactions | 3.50e-04 | 254 | 104 | 7 | int:CRX | |
| Interaction | GNA11 interactions | 3.52e-04 | 117 | 104 | 5 | int:GNA11 | |
| Interaction | NUP50 interactions | 3.89e-04 | 341 | 104 | 8 | int:NUP50 | |
| Interaction | DLEC1 interactions | 3.90e-04 | 6 | 104 | 2 | int:DLEC1 | |
| Interaction | ZNF280B interactions | 3.90e-04 | 6 | 104 | 2 | int:ZNF280B | |
| Interaction | ESRRB interactions | 4.21e-04 | 262 | 104 | 7 | int:ESRRB | |
| Interaction | LGR4 interactions | 4.21e-04 | 262 | 104 | 7 | int:LGR4 | |
| Interaction | ALDH18A1 interactions | 4.45e-04 | 189 | 104 | 6 | int:ALDH18A1 | |
| Interaction | MYH9 interactions | SHROOM3 RAD18 USP45 PAGE4 TGOLN2 RNF123 CTCF GNAI1 GNAI2 OTUD3 EIF3C PML | 5.10e-04 | 754 | 104 | 12 | int:MYH9 |
| Interaction | ERLEC1 interactions | 5.32e-04 | 128 | 104 | 5 | int:ERLEC1 | |
| Interaction | RPS6KA2 interactions | 5.40e-04 | 196 | 104 | 6 | int:RPS6KA2 | |
| Interaction | ZNF784 interactions | 5.40e-04 | 31 | 104 | 3 | int:ZNF784 | |
| Interaction | GPSM2 interactions | 5.40e-04 | 31 | 104 | 3 | int:GPSM2 | |
| GeneFamily | PDZ domain containing | 1.87e-04 | 152 | 63 | 5 | 1220 | |
| GeneFamily | Non-canonical poly(A) polymerases | 2.48e-04 | 7 | 63 | 2 | 1318 | |
| GeneFamily | PHD finger proteins | 2.73e-04 | 90 | 63 | 4 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.22e-03 | 15 | 63 | 2 | 529 | |
| GeneFamily | OTU domain containing | 1.57e-03 | 17 | 63 | 2 | 669 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.14e-03 | 24 | 63 | 2 | 485 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 3.40e-03 | 25 | 63 | 2 | 74 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | UBR2 FLT3 MIA3 RBBP6 TBC1D5 ZMYND8 DHDDS GOLPH3 RMDN3 UPF2 ELMO2 RALBP1 PAXIP1 OTUD4 KMT2A GNAI3 HADH TASOR S100PBP | 2.78e-07 | 1215 | 104 | 19 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 UBR2 TUT4 ZEB1 AUH ZMYND8 NVL CLASP2 UPF2 CTCF OTUD4 GNAI1 SPEN TASOR PLCE1 | 1.45e-06 | 856 | 104 | 15 | M4500 |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 1.44e-05 | 198 | 104 | 7 | M9346 | |
| Coexpression | GSE3982_DC_VS_BASOPHIL_DN | 1.49e-05 | 199 | 104 | 7 | M5473 | |
| Coexpression | GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP | 1.54e-05 | 200 | 104 | 7 | M4135 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | UBR2 CERK TUT4 ZEB1 ARID4B RBBP6 JMJD1C TGOLN2 KMT2C CTCF ELMO2 OTUD4 KMT2A BOD1L1 GNAI2 GNAI3 SPEN TASOR | 2.20e-05 | 1492 | 104 | 18 | M40023 |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 3.19e-05 | 224 | 104 | 7 | M2500 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN | 1.01e-04 | 23 | 104 | 3 | M10172 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.01e-04 | 466 | 104 | 9 | M13522 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN | 1.34e-04 | 196 | 104 | 6 | M8438 | |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | 1.38e-04 | 197 | 104 | 6 | M5475 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN | 1.49e-04 | 200 | 104 | 6 | M5005 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 1.49e-04 | 200 | 104 | 6 | M7031 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | 1.49e-04 | 200 | 104 | 6 | M8278 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP | 1.49e-04 | 200 | 104 | 6 | M7879 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 1.49e-04 | 200 | 104 | 6 | M7150 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 1.49e-04 | 200 | 104 | 6 | M9133 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ZEB1 ARID4B TBC1D5 DIDO1 ZNF407 JMJD1C RMDN3 GTF2E1 UPF2 GNAI1 TASOR ZHX1 | 1.69e-05 | 564 | 102 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZEB1 ARID4B RBBP5 TBC1D5 DIDO1 ZNF407 UPF2 CTCF BOD1L1 GNAI1 GNAI3 TASOR | 2.85e-05 | 595 | 102 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.56e-07 | 200 | 104 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.31e-06 | 188 | 104 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 190 | 104 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.99e-06 | 192 | 104 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 195 | 104 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 195 | 104 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-06 | 199 | 104 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.56e-06 | 200 | 104 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.64e-05 | 135 | 104 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.63e-05 | 149 | 104 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-05 | 178 | 104 | 5 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.47e-05 | 180 | 104 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 7.00e-05 | 183 | 104 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 184 | 104 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.56e-05 | 186 | 104 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-05 | 188 | 104 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-05 | 188 | 104 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-05 | 188 | 104 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 8.35e-05 | 190 | 104 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.56e-05 | 191 | 104 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 8.77e-05 | 192 | 104 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 8.99e-05 | 193 | 104 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.21e-05 | 194 | 104 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.21e-05 | 194 | 104 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 9.67e-05 | 196 | 104 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 9.90e-05 | 197 | 104 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.90e-05 | 197 | 104 | 5 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 9.90e-05 | 197 | 104 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 198 | 104 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.01e-04 | 198 | 104 | 5 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.01e-04 | 198 | 104 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 198 | 104 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 199 | 104 | 5 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-04 | 200 | 104 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.44e-07 | 182 | 103 | 9 | 3887_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.73e-05 | 179 | 103 | 7 | 4585_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.80e-05 | 180 | 103 | 7 | 4541_DN | |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A | 1.86e-05 | 181 | 103 | 7 | 6048_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 1.86e-05 | 181 | 103 | 7 | 1791_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 2.30e-05 | 187 | 103 | 7 | 7080_DN | |
| Drug | Alsterpaullone; Down 200; 10uM; MCF7; HT_HG-U133A | 2.30e-05 | 187 | 103 | 7 | 7051_DN | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 2.22e-06 | 8 | 102 | 3 | DOID:1858 (implicated_via_orthology) | |
| Disease | metabolic syndrome | 6.34e-06 | 200 | 102 | 7 | EFO_0000195 | |
| Disease | Mixed phenotype acute leukemia | 1.18e-05 | 2 | 102 | 2 | C2826025 | |
| Disease | neutrophil count, eosinophil count | 9.98e-05 | 213 | 102 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | Acute myelomonocytic leukemia | 1.18e-04 | 5 | 102 | 2 | C0023479 | |
| Disease | functional brain measurement, language measurement | 1.23e-04 | 28 | 102 | 3 | EFO_0007797, EFO_0007849 | |
| Disease | neutrophil count, basophil count | 1.31e-04 | 224 | 102 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | serum albumin measurement | 2.17e-04 | 592 | 102 | 9 | EFO_0004535 | |
| Disease | obsolete_red blood cell distribution width | FLT3 RBBP5 TBC1D5 TUT7 SH3GL1 NVL DHDDS ZNF407 ABCA7 INTS10 RNF123 NFRKB SLC7A5 CDCA5 | 2.22e-04 | 1347 | 102 | 14 | EFO_0005192 |
| Disease | Acute erythroleukemia - M6a subtype | 3.27e-04 | 8 | 102 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 3.27e-04 | 8 | 102 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 3.27e-04 | 8 | 102 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 3.27e-04 | 8 | 102 | 2 | C2930974 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 3.35e-04 | 39 | 102 | 3 | EFO_0008298 | |
| Disease | myeloid white cell count | UBR2 FLT3 RBBP5 DHDDS ABCA7 JMJD1C TGOLN2 SNX32 NOSTRIN PLCE1 TGS1 | 4.01e-04 | 937 | 102 | 11 | EFO_0007988 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.66e-04 | 200 | 102 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 7.64e-04 | 12 | 102 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | immature platelet measurement | 7.88e-04 | 119 | 102 | 4 | EFO_0803541 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 8.39e-04 | 121 | 102 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Acute Myeloid Leukemia, M1 | 9.47e-04 | 125 | 102 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 9.47e-04 | 125 | 102 | 4 | C1879321 | |
| Disease | eosinophil percentage of leukocytes | 1.14e-03 | 746 | 102 | 9 | EFO_0007991 | |
| Disease | neutrophil percentage of leukocytes | 1.27e-03 | 610 | 102 | 8 | EFO_0007990 | |
| Disease | basophil count | 1.46e-03 | 483 | 102 | 7 | EFO_0005090 | |
| Disease | Amnesia | 1.56e-03 | 17 | 102 | 2 | C0002622 | |
| Disease | Tactile Amnesia | 1.56e-03 | 17 | 102 | 2 | C0750906 | |
| Disease | Amnestic State | 1.56e-03 | 17 | 102 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 1.56e-03 | 17 | 102 | 2 | C0236795 | |
| Disease | Global Amnesia | 1.56e-03 | 17 | 102 | 2 | C0262497 | |
| Disease | Hysterical amnesia | 1.56e-03 | 17 | 102 | 2 | C0233750 | |
| Disease | Acute myeloid leukemia | 1.56e-03 | 17 | 102 | 2 | cv:C0023467 | |
| Disease | Temporary Amnesia | 1.56e-03 | 17 | 102 | 2 | C0233796 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.56e-03 | 17 | 102 | 2 | 601626 | |
| Disease | mean reticulocyte volume | 1.82e-03 | 799 | 102 | 9 | EFO_0010701 | |
| Disease | eosinophil count | DOCK3 UBR2 AUH TBC1D5 ZMYND8 GSDMB DHDDS GK5 GOLPH3L SLC7A5 GNAI2 NOSTRIN GPN3 | 1.85e-03 | 1488 | 102 | 13 | EFO_0004842 |
| Disease | erythrocyte measurement | 2.02e-03 | 257 | 102 | 5 | EFO_0005047 | |
| Disease | lean body mass | 2.06e-03 | 379 | 102 | 6 | EFO_0004995 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.38e-03 | 21 | 102 | 2 | C1292769 | |
| Disease | interleukin 10 measurement | 2.53e-03 | 78 | 102 | 3 | EFO_0004750 | |
| Disease | Granulomatous Slack Skin | 2.61e-03 | 22 | 102 | 2 | C0376407 | |
| Disease | citrate measurement | 2.62e-03 | 79 | 102 | 3 | EFO_0010114 | |
| Disease | cystatin C measurement | 2.77e-03 | 402 | 102 | 6 | EFO_0004617 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.86e-03 | 23 | 102 | 2 | C0079773 | |
| Disease | C-reactive protein measurement | DOCK3 DOCK4 UBR2 ZEB1 DHDDS GK5 EIF3CL PAX8 GNAI2 EIF3C ANAPC5 | 3.03e-03 | 1206 | 102 | 11 | EFO_0004458 |
| Disease | Leukemia, Myelocytic, Acute | 3.10e-03 | 173 | 102 | 4 | C0023467 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.12e-03 | 84 | 102 | 3 | DOID:9119 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KASKMSSPETDEEIE | 381 | Q6UWZ7 | |
| SSDEDEEETKAKMTP | 861 | Q4LE39 | |
| SKEGELDARDLEMSK | 126 | Q96FF9 | |
| KMRSKKEDSSDSENA | 601 | P49711 | |
| DSEDVSKRDSDKEMA | 111 | Q02952 | |
| LGSEDSRNMKEKLED | 246 | Q8TAX9 | |
| GEELAKLEAKSSEEM | 421 | Q8N4X5 | |
| ASTELDKEKARVDSM | 426 | Q569K6 | |
| DRREETSIGMKSSDE | 151 | Q6P1M9 | |
| ESKNGEADSSDKEMK | 201 | Q9C0F0 | |
| DTDMEGSVDTRQEKK | 1051 | Q8IZY2 | |
| DSSGDEAESPSKMKR | 91 | Q15311 | |
| LKIKEERSGMTTDDD | 916 | Q6ZMN7 | |
| PGSDKRKMDDSDQDS | 191 | Q06710 | |
| RMDTEERKDKDSIHG | 506 | Q01804 | |
| KEDESTEKLSSVCMG | 376 | Q9NS91 | |
| QDGSREDMSDIKLEK | 181 | Q9H0N0 | |
| QDGSREDMSDIKLEK | 181 | Q53S08 | |
| PDSKMFETEADEKRE | 676 | P49796 | |
| KKDDGDAAMGSRLTE | 926 | Q6P2E9 | |
| SAEDKAAVERSKMID | 6 | P63096 | |
| DSKDSSLLESDMKRK | 206 | O15381 | |
| KLAEGREKTMSSDDE | 371 | Q9NVR2 | |
| REKTMSSDDEDCSAK | 376 | Q9NVR2 | |
| KRTAQGSEDEDMATK | 531 | Q8IW93 | |
| ELTSRDEGERKMEKE | 176 | Q9UJX4 | |
| MESKLGSLRDEESEE | 301 | Q8IYY4 | |
| EKSKGELMFDDSSDS | 241 | Q6ZW49 | |
| MDLEKTRSERGDGSD | 66 | O60829 | |
| ESIAKDMSLKDSGSD | 151 | O95251 | |
| RSRGKTAVEDEDSMD | 56 | Q8NEZ4 | |
| TTDMKTADKVELGDS | 241 | Q6P4R8 | |
| SAEDKAAVERSKMID | 6 | P08754 | |
| ADLKERAKMSSSEVG | 141 | Q13825 | |
| RGDASKEDIDTAMKL | 236 | Q16836 | |
| GSDSSIPDEEKMKEE | 316 | Q15652 | |
| LKIREERSGMTTDDD | 651 | Q76G19 | |
| EAREKMLAAKSADGS | 21 | Q01650 | |
| SKDGDVKDMLSRDRE | 536 | Q9HAQ2 | |
| KDSMGADKEDLSDKL | 266 | Q9NQN1 | |
| VSSKKDMVEESEAGR | 96 | Q96PH6 | |
| SLMDEGASSEKKRQS | 426 | Q15291 | |
| TEEKGVDKDFESSSM | 1151 | Q7Z6E9 | |
| KIKTKGMDSEDDLRD | 216 | Q5T2D3 | |
| STDKERTSEDMADKE | 246 | Q8NFC6 | |
| RTSEDMADKEKSTAD | 251 | Q8NFC6 | |
| GESRKFLKKMDDEDE | 206 | Q99613 | |
| LKEKADSSEREALMS | 646 | P36888 | |
| GESRKFLKKMDDEDE | 206 | B5ME19 | |
| DSGDGEDELEMTKRL | 141 | P48547 | |
| KEPKEREDESSSMFD | 261 | Q9UHW5 | |
| DKLDSMVSEGKGDES | 1141 | Q8IZD9 | |
| IDKLDSLMSEGKGDE | 1111 | Q8N1I0 | |
| LGKDMSSELTKSDLD | 666 | Q96JJ3 | |
| TSKHMEDEDSDLKEG | 461 | Q8TCT0 | |
| EKRYDASKGMESLED | 936 | Q6P158 | |
| EDSGDSKDIRLTLME | 36 | Q9H4A5 | |
| KRTDEDKAKSMLGTD | 71 | Q7Z4T8 | |
| TKEDRRSEEKAAAMA | 531 | Q9BTC0 | |
| DKGDSKETRLTLMEE | 51 | Q9H4A6 | |
| KKKMENESATEGEDS | 456 | Q9HCJ1 | |
| AETEKMAKSLEDSEG | 356 | Q6ZS86 | |
| REKILSSMGNDDKSS | 1101 | Q03164 | |
| NKAEEDGLSKMEDST | 276 | D6RIA3 | |
| ENFKRSKSEVDGLMD | 81 | Q86SQ9 | |
| DRSKAEMDLKELSES | 521 | Q9ULU4 | |
| TEKLSSLGEEMREDG | 171 | Q96BU1 | |
| MALAKEESEKAAESR | 911 | Q9UPN4 | |
| DKDSKDSMTEGENLE | 1016 | Q9HAU5 | |
| EEDPNSAMDKERRKS | 286 | Q8IVI9 | |
| MKDEAGERDREVSSL | 1 | Q8TBY8 | |
| DEEKQMKGFLDDSER | 1171 | Q8NET4 | |
| VEEDESAMPKKDART | 161 | P29083 | |
| KMAEGKASRESEEES | 21 | O14607 | |
| KMGRKDSLDLEEEAA | 206 | Q96TC7 | |
| MSEKIRLSEGEAKED | 671 | Q5JRA6 | |
| SGEVTDDEMATRKAK | 1096 | Q9P212 | |
| MESEEGKEARLARSS | 491 | P29590 | |
| SAEDKAAAERSKMID | 6 | P04899 | |
| GAEMESSKEDKARQA | 141 | Q9H173 | |
| AGKSMSAEDLLERSD | 1216 | Q8TF72 | |
| MKSEAKDGEEESLQT | 1 | Q9NX31 | |
| KMSSPEDDSDTKRLS | 381 | Q15424 | |
| RKKSVGGDSDTEDMR | 691 | Q9UK61 | |
| EGLKDKEDSDSMTNT | 631 | Q8IVF2 | |
| EGDLSLADKDMTAKD | 1971 | Q8IVF2 | |
| EGDMSLADKDVTAKD | 2301 | Q8IVF2 | |
| EGDLSLADKDMTAKD | 3951 | Q8IVF2 | |
| EGDLSLADKDMTAKD | 4281 | Q8IVF2 | |
| QLMSKGDEDTKDDSE | 536 | P35612 | |
| LDSEIKKNSDGMEAA | 91 | Q9UJ71 | |
| EPLKRDSKKDDGDSM | 961 | O75122 | |
| EEKEKMSGSASSENR | 341 | O43493 | |
| DAGESMKRLAEVKDS | 116 | Q99961 | |
| KETDSGDKEMAEAIS | 546 | Q70EL2 | |
| RTDSEGKMDDKKEDH | 1501 | Q96T58 | |
| TVEDSGESLEDLMAK | 386 | Q9GZZ9 | |
| CSSREGKESTEMKEE | 461 | Q5XPI4 | |
| GKESTEMKEETAEER | 466 | Q5XPI4 | |
| KEEKMEIDESNAGSS | 626 | Q9UKY1 | |
| GTDASLDEELDRVKM | 341 | Q9UJZ1 | |
| MEDGKTSVSKEELEK | 1821 | Q8IUG5 | |
| EAKTEGLMKDDRAES | 1086 | P37275 | |
| AGPSMKSDEDKDDVT | 126 | Q8N6K0 | |
| SKTMGRKESEEELEA | 576 | Q92609 | |
| LESENAKESMDDSGK | 666 | Q9C0G0 | |
| SSDSEEQDMSVKKGD | 546 | Q96RS0 | |
| KRTKDRGTMDDDDFR | 11 | Q5VYS8 | |
| EGDSSVTREEFAKMK | 106 | Q86XE0 | |
| GIEDVSDDLSKMKND | 231 | Q5TAX3 | |
| GTIMEESSRDKDKAE | 1016 | Q8IWV8 |